IceCure Medical Ltd. financial data

Symbol
ICCM on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
7 Ha'eshel St., Pob 3163, Caesarea, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
Q4 2023 - Apr 3, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Operating Margin -543 % -131%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +0.23%
Common Stock, Shares, Outstanding 45.7M shares +0.23%
Weighted Average Number of Shares Outstanding, Basic 45.6M shares +23.3%
Weighted Average Number of Shares Outstanding, Diluted 45.6M shares +23.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.09M USD -25.4%
Cost of Revenue 1.93M USD +17.6%
Research and Development Expense 8.27M USD -9.32%
Selling and Marketing Expense 4.44M USD +38.5%
General and Administrative Expense 4.17M USD -28.9%
Operating Income (Loss) -15.6M USD +6.95%
Nonoperating Income (Expense) 924K USD
Net Income (Loss) Attributable to Parent -14.7M USD +13.7%
Earnings Per Share, Basic 0.32 USD/shares -30.4%
Earnings Per Share, Diluted 0.32 USD/shares -30.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.5M USD -55.5%
Accounts Receivable, after Allowance for Credit Loss, Current 103K USD +32.1%
Inventory, Net 2.28M USD -20.4%
Assets, Current 14.2M USD -49.6%
Property, Plant and Equipment, Net 1.51M USD +11.6%
Operating Lease, Right-of-Use Asset 679K USD +1.65%
Assets 16.4M USD -45.6%
Accounts Payable, Current 502K USD -29.7%
Employee-related Liabilities, Current 3.46M USD +18.5%
Liabilities, Current 3.87M USD -10.7%
Operating Lease, Liability, Noncurrent 376K USD -12.6%
Liabilities 4.25M USD -13.8%
Retained Earnings (Accumulated Deficit) -90.1M USD -19.4%
Stockholders' Equity Attributable to Parent 12.2M USD -52.2%
Liabilities and Equity 16.4M USD -45.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD +12.4%
Net Cash Provided by (Used in) Financing Activities 83K USD -99.4%
Net Cash Provided by (Used in) Investing Activities -713K USD +20%
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 45.7M shares +0.23%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.61M USD -107%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.5M USD -55.5%
Deferred Tax Assets, Valuation Allowance 18.8M USD +8.34%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.23 pure 0%
Deferred Tax Assets, Gross 18.8M USD +8.34%
Operating Lease, Liability 599K USD +0.34%
Depreciation 323K USD +30.2%
Payments to Acquire Property, Plant, and Equipment 480K USD -46.1%
Lessee, Operating Lease, Liability, to be Paid 678K USD
Property, Plant and Equipment, Gross 2.73M USD +20.8%
Operating Lease, Liability, Current 223K USD +33.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 257K USD +31.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 276K USD +29%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +43.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 79K USD -88.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 145K USD -20.3%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +8.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 105K USD -46.4%
Operating Lease, Payments 246K USD +1.65%
Additional Paid in Capital 102M USD +1.38%
Current State and Local Tax Expense (Benefit) 14.7M USD -13.6%
Share-based Payment Arrangement, Expense 1.87M USD +490%